Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Tracy McGee

Orthopaedic Surgery Albany, GA Medical Doctor

NPI 1487620605 CMS profile 21259

2311 Lake Park Dr, Albany, GA 31707

Open in the dashboard

General payments

$485

16 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Tracy McGee of Albany, GA is reported in the CMS Open Payments database as having received $485 across 16 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 22nd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $28 1
2024 General $39 2
2023 General $102 4
2022 General $144 2
2021 General $97 4
2020 General $31 1
2019 General $43 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tracy McGee
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Tracy McGee were reported at $28. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Tracy McGee Orthopaedic Surgery median Middle half National median
2019 $43 $644 $140–$2,844 $163
2020 $31 $312 $75–$1,860 $114
2021 $97 $520 $117–$2,495 $132
2022 $144 $598 $128–$2,731 $149
2023 $102 $461 $128–$2,264 $160
2024 $39 $497 $134–$2,475 $164
2025 $28 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $118 1 payment
  2. Djo, LLC $109 4 payments
  3. DePuy Synthes Sales Inc. $59 2 payments
  4. Pacira Pharmaceuticals Incorporated $32 1 payment
  5. Biocomposites Inc $28 1 payment
  6. Seaspine Orthopedics Corporation $27 1 payment
  7. KCI USA, Inc $24 1 payment
  8. ERMI Inc. $22 1 payment
  9. ConvaTec Inc. $21 1 payment
  10. Baxter Healthcare $18 1 payment
  11. Other $28 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $485 16 payments
Products named General payments · program years 2019–2025
  1. General - Pain Management $118 1 payment
  2. CMF $94 3 payments
  3. MONOVISC $59 2 payments
  4. Iovera $32 1 payment
  5. Exparel $32 1 payment
  6. Zilretta $32 1 payment
  7. CHATTANOOGA $30 1 payment
  8. Stimulan $28 1 payment
  9. 7D Surgical System $27 1 payment
  10. PREVENA $24 1 payment
  11. Other $132 9 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 17 drugs

Part D claims

1,128

Median for Orthopedic Surgery: 203

Drug cost

$8,618

Median for Orthopedic Surgery: $1,433

Branded share of claims

7.7%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 308 $1,953
Diclofenac Sodium Generic 55 $1,660
Cephalexin Generic 76 $1,147
Methylprednisolone Generic 152 $952
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 63 $613
Calcitonin-Salmon Calcitonin,salmon,synthetic Brand 11 $580
Meloxicam Generic 225 $373
Clindamycin Hcl Generic 16 $264
Ibuprofen Generic 14 $173
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 13 $171

The 10 drugs with the highest cost, of 17 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 80 billing codes

Paid by Medicare

$106,494

Of which drugs: $14,542

Medicare patients

269

Average age 75

Services billed

2,092

159 women, 110 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Chronic kidney disease 32%
Diabetes 30%
Ischemic heart disease 24%
Depression 22%
COPD 21%
Osteoporosis 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose J7324 Office 29 146 $14,121
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 68 413 $307
Injection, ketorolac tromethamine, per 15 mg J1885 Office 18 96 $47

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

16 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record